Beauty Farm Medical and Health Industry Inc. executed an on-market repurchase of 25,000 ordinary shares on 08 June 2026.

• Volume and Pricing: The shares were bought back on the Hong Kong Stock Exchange at prices ranging from HKD 16.74 to HKD 17.29, for a volume-weighted average of HKD 16.99. Total consideration reached HKD 0.42 million.

• Impact on Share Capital: – Issued shares (excluding treasury shares) declined by 25,000—or 0.01%—to 249.10 million. – Treasury shares increased to 2.49 million, keeping total issued shares unchanged at 251.59 million.

• Repurchase Capacity: The transaction was executed under the repurchase mandate approved on 27 June 2025, which authorises buybacks of up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 2.49 million shares, equivalent to 1.06% of the issued share base at the mandate date.

• Post-Repurchase Restrictions: In line with Hong Kong listing rules, Beauty Farm is restricted from issuing, selling or transferring any shares or treasury shares until 08 July 2026.

The board confirmed that the buyback complied with all relevant listing rules and regulatory requirements.